Allscripts to hold meeting for investors on August 8

CHICAGO, Aug. 07, 2017 (GLOBE NEWSWIRE) -- Allscripts MDRX will hold a meeting for its investor community during the company's annual user conference, the 2017 Allscripts Client Experience (ACE).

The Investor Meeting will begin on Tuesday, August 8 at noon Central time with a Q&A session with Allscripts Chief Financial Officer Dennis Olis. Participants will spend the afternoon in educational sessions, the general welcome session for all attendees and conclude with the ACE Social in the exhibit hall. It will conclude at approximately 6 p.m. Central time.

Learn more about ACE 2017 here. Investors can access a live webcast of the Q&A portion of the event on our investor relations website.

About Allscripts

Allscripts MDRX is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2017 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

For more information contact:

Investors:
Seth Frank
312-506-1213
seth.frank@allscripts.com

Media: 
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

Primary Logo

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!